ECE2017 Eposter Presentations: Adrenal and Neuroendocrine Tumours Adrenal cortex (to include Cushing's) (86 abstracts)
1Coimbra Hospital and University Center, Coimbra, Portugal; 2Faculty of Medicine University of Coimbra, Coimbra, Portugal.
Background: The diagnosis of Cushings syndrome (CS) remains a challenge in clinical endocrinology. Several screening tests have been proposed to establish hypercortisolism. Late-night salivary cortisol (LNSC) is used as screening tool, however, individualized cut-off levels for each population must be defined.
Methods: Three group of subjects were studied: healthy volunteers, suspected CS and proven CS. All patients collected saliva at 23.00 h using a Salivette. Salivary Cortisol was measured using an automated electrochemiluminescence assay Elecsys 2010-Roche. The functional sensitivity of the assays is 0.018 μg/dl. Diagnostic cut-off level was defined by Receiver operating characteristic (ROC) curve and Youdens J index.
Results: We studied 127 subjects: 57 healthy volunteers, 39 patients with suspected CS and 31 with proven CS (ACTH-dependent: 22 pituitary, two ectopic; ACTH-independent: two adrenal adenoma, five adrenal carcinoma).
The 2.5th97.5th percentile of the LNSC concentrations in normal subjects was 0.0540.1827 μg/dl, respectively. The mean±S.D. LNSC concentration in patients with proven CS (0.6798±0.52 μg/dl) was significantly higher than those in normal subjects (0.0642±0.03 μg/dl; P<0.0001) and suspected CS group (0.1803±0.19 μg/dl; P<0.0001).
ROC curve analysis showed an AUC of 0.9881 (P<0.0001) and a cut-off point of 0.1 μg/dl provides a sensibility (S) of 96.77% (95%CI 83.3-99.92%) and specificity (E) of 91.23% (95%CI 80.797.09%).
There were significant correlations between LNSC and late-night serum cortisol (LNSeC) levels (r=0.6977; P<0.0001) as well as with Urinary Free Cortisol (UFC) levels (r=0.5404; P 0.0025) in proven CS group.
Conclusion: Our results give to LNSC an excellent accuracy and reaffirm that can be used as a highly reliable noninvasive screening tool for outpatient assessment. In our population, the LNSC reference cut-off was 0.1 μg/dl with S 96.77% and E 91.23% for CS diagnosis. Given its convenience and diagnostic accuracy, LNSC may profitably be added to traditional screening tests such as LNSeC and UFC.